Navigation Links
Pharmasset to Webcast an Investor Event From the EASL Meeting
Date:3/28/2011

PRINCETON, N.J., March 28, 2011 /PRNewswire/ -- Pharmasset, Inc. (Nasdaq: VRUS) today announced that it will webcast an investor event from the European Association for the Study of the Liver (EASL) on Saturday, April 2, 2011 starting at 8:00pm CET. During this webcast, management will review Pharmasset's progress on the programs that are the subject of presentations at EASL.

To access a simultaneous webcast of this event via the internet, log on to the "Events & Presentations" section of the Investor Center on Pharmasset's website at http://investor.pharmasset.com/events.cfm. Please connect to the website at least ten minutes prior to the start of the presentation to ensure adequate time for a reliable connection and any software download that may be necessary for the webcast.

PSI-7977

Abstract (oral)

"Once Daily PSI-7977 plus PegIFN/RBV: Rapid Virologic Suppression in Treatment Naive Patients with HCV GT2/GT3 in a Phase 2b Trial" will be presented in the HCV Drug Development session on Friday, April 1 at 4:15pm CET. Authors of the study are Lalezari, J. et al.

Abstract 1372

"Once Daily PSI-7977 Plus Peg-IFN/RBV in HCV GT1: 98% Rapid Virologic Response, Complete Early Virologic Response: The PROTON Study" will be presented in a late breaker poster session on Thursday, March 31. Authors of the study are Nelson, DR. et al.

PSI-938

Abstract 1235

"PSI-352938, A Novel Purine Nucleotide Analog, Exhibits Potent Antiviral Activity and No Evidence of Resistance in Patients With HCV Genotype 1 Over 7 Days" will be presented in a poster session on Saturday, April 2. Authors of the study are Rodriguez-Torres M. et al.

Abstract 1217

"Mechanism of HCV Replicon Resistance to PSI-352938, a Cy
'/>"/>

SOURCE Pharmasset, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Pharmasset to Present at Three Upcoming Investor Conferences
2. Pharmasset to Present at the Leerink Swann Hot Topics Roundtable Conference
3. Pharmasset Reports Fiscal First Quarter 2011 Financial Results
4. Pharmasset Announces Exercise of Underwriters Overallotment Option
5. Pharmasset Prices Public Offering of Common Stock
6. Pharmasset Announces Proposed Public Offering of Common Stock
7. Pharmasset Reports Positive Results from its HCV Clinical Programs
8. Pharmasset to Present at the 29th Annual J.P. Morgan Healthcare Conference
9. Pharmasset Initiates Exploratory Interferon Sparing Clinical Trial of PSI-7977 for Chronic Hepatitis C
10. Pharmasset to Webcast an Investor Event from the AASLD Meeting
11. Pharmasset to Present at the JMP Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/17/2014)... DUBLIN , Oct. 17, 2014 ... of the "Research and Development Prospect of ... offering. Based on the 2013 ... Chinese government policies about dialysis industry and the ... in-depth research about dialysis industry segmentations. Moreover, it ...
(Date:10/17/2014)... , Oct. 17, 2014 The ... Medical Technology Policy: The Green Park ... FDA, public and private payers, medical device and ... and other experts January 12, 2015 at its ... value of weight loss treatments.  Participants will discuss ...
(Date:10/17/2014)... , Oct. 17, 2014  China Biologic ... "Company"), a leading fully integrated plasma-based biopharmaceutical company ... that the Company has received approval from the ... commercial manufacturing of human prothrombin complex concentrate ("PCC") ... Shandong Taibang,s new coagulation factor production facility for ...
Breaking Medicine Technology:Research and Development Prospect of China Dialysis Market, 2014-2018 2Research and Development Prospect of China Dialysis Market, 2014-2018 3Green Park Collaborative to Discuss Comparative Effectiveness and Value of Weight Loss Treatments 2China Biologic Receives Approval for Commercial Manufacturing of Human Prothrombin Complex Concentrate at Shandong Taibang Facility 2China Biologic Receives Approval for Commercial Manufacturing of Human Prothrombin Complex Concentrate at Shandong Taibang Facility 3
... Nov. 15 GeoVax Labs, Inc. (OTC,Bulletin Board: GOVX), ... results and provided an,operational update for the quarter ended ... Ended September 30, 2007 The Company recorded a ... 30, 2007, compared to $283,434 for the same period ...
... Collaborative Meeting Includes Leading Scientists Investigating ... Pregnancy and Breast Cancer Prevention, HOUSTON, Nov. ... breast cancer by studying the natural,impact of pregnancy on breast ... November 12, 2007 to share interim findings. All are,part of ...
Cached Medicine Technology:GeoVax Labs, Inc. Third Quarter Financial Results and Operational Update 2GeoVax Labs, Inc. Third Quarter Financial Results and Operational Update 3GeoVax Labs, Inc. Third Quarter Financial Results and Operational Update 4GeoVax Labs, Inc. Third Quarter Financial Results and Operational Update 5GeoVax Labs, Inc. Third Quarter Financial Results and Operational Update 6GeoVax Labs, Inc. Third Quarter Financial Results and Operational Update 7GeoVax Labs, Inc. Third Quarter Financial Results and Operational Update 8GeoVax Labs, Inc. Third Quarter Financial Results and Operational Update 9GeoVax Labs, Inc. Third Quarter Financial Results and Operational Update 10Grantees of the Avon Foundation Breast Cancer Prevention Research Initiative Gather in Houston to Report Interim Findings 2Grantees of the Avon Foundation Breast Cancer Prevention Research Initiative Gather in Houston to Report Interim Findings 3
(Date:10/20/2014)... Principle Business Enterprises, a family owned company for ... products. The company has recently made efforts to ... Premium Protection absorbent products. The company has redesigned ... a new look, and is currently working on innovative ... , The new website, developed with Thread Marketing Group ...
(Date:10/20/2014)... Succeed is proud to announce that they ... in the Every Body Walk! campaign by Kaiser ... that encourages workers to be more active outside of the ... concluded at the end of September, was a friendly competition ... areas. Participating companies gave their staff pedometers and each ...
(Date:10/20/2014)... Unveiled at the Sept. 18 board meeting, The Center ... hospital ROI on membership dues at 12.5. In other words, ... in value to member hospitals. The calculation used to determine ... , “This is the first time we’ve actually been ... methodology is really sound,” said Bill Ryan , president ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 Do you ... interventions? Here comes a wonderful app Metassessor for teachers, ... development company helped its client “Intervention Development LLC” ... The app is designed for iOS 4.3 or later ... This app is optimized for iPhone 5. It is ...
(Date:10/19/2014)... 19, 2014 Dr. Babatunde Osotimehin, Executive ... news of a ceasefire agreement that is expected to ... girls who were kidnapped from the north-eastern Nigerian town ... captivity long enough, and it is high time they ... Dr. Osotimehin. , "We owe it to these girls ...
Breaking Medicine News(10 mins):Health News:Tranquility® Premium Protection Incontinence Products Releases New Logo and Website 2Health News:Succeed Management Solutions, LLC Competes in Walking Challenge and Achieves 12th Place in Portland 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 3Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 4Health News:Metassessor App Launched: an RTI tool for Teachers & Parents 2Health News:Metassessor App Launched: an RTI tool for Teachers & Parents 3
... Metropolitan Health Plan (MHP(R)),the HMO of Hennepin County, announced ... Financial Officer and David R. Johnson,Executive Director., David ... for over 35,years. During his tenure at MHP, the ... Assistance, to a plan that offers 10 government,sponsored plans ...
... A key protein change can lessen the cholesterol-lowering drugs, ... genetic quirk in the production of one protein helps ... benefit of statin drugs, researchers report. , Statins include ... , The protein, abbreviated as HMGCR, plays a critical ...
... Many women experience menopausal changes in their body ... they don,t notice can be more dangerous. In a ... discovered significant changes in the brain,s vascular system when ... currently used estrogen-based hormone therapies may complicate this process ...
... PITTSBURGH, June 16 Mylan Inc. (NYSE: ... Inc., has,received final approval from the U.S. Food ... Application (ANDA) for Venlafaxine,Hydrochloride (HCl) Tablets 25 mg ... (base) and 100 mg (base)., Venlafaxine HCl ...
... 16 /PRNewswire-FirstCall/ - MaxLife Fund Corp.,(OTC:MXFD), is pleased to ... shareholders of its outstanding preferred shares. The,dividend declared is ... quarterly. Each preferred share was sold at $25 per ... Fund Corp., The dividend is payable August 31, ...
... studies evaluating dietary changes and complementary medicine for the ... at Rush University Medical Center. Funded by the ... the impact of mind/body medicine on patients suffering from ... diet impacts patients with Crohn,s Disease. , ...
Cached Medicine News:Health News:Metropolitan Health Plan Announces Senior Management Appointments 2Health News:Research Shows Why Statins Don't Work for Everyone 2Health News:Complex changes in the brain's vascular system occur after menopause 2Health News:MaxLife Fund Corp. declares dividends to shareholders of Preferred Shares. 2Health News:Study underway to find an alternative cure for Crohn's disease and ulcerative colitis 2
... tests confirmed Sterillium Rub's extremely effective and ... (Time Kill study and Tentative Final Monograph ... one European test - with the result ... efficacy specifications. Sterillium Rub with its high ...
Chlorhexidine Gluconate, exceptionally persistent and broad spectrum antimicrobial properties have led to its recognition as the most effective agent available for surgical scrubbing, hand washing, p...
Amino+Derm moisturizers and soaps are specifically engineered to aid in the prevention of skin irritations and to help maintain healthy, intact skin....
... plus Neu Thera is ... alcohol hand sanitizer that ... of the Neu-Thera technology. ... clinically proven to be ...
Medicine Products: